» Articles » PMID: 25364577

Heterogeneity and Renal Mass Biopsy: a Review of Its Role and Reliability

Overview
Journal Cancer Biol Med
Specialty Oncology
Date 2014 Nov 4
PMID 25364577
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Increased abdominal imaging has led to an increase in the detection of the incidental small renal mass (SRM). With increasing recognition that the malignant potential of SRMs is heterogeneous, ranging from benign (15%-20%) to aggressive (20%), enthusiasm for more conservative management strategies in the elderly and infirmed, such as active surveillance (AS), have grown considerably. As the management of the SRM evolves to incorporate ablative techniques and AS for low risk disease, the role of renal mass biopsy (RMB) to help guide individualized therapy is evolving. Historically, the role of RMB was limited to the evaluation of suspected metastatic disease, renal abscess, or lymphoma. However, in the contemporary era, the role of biopsy has grown, most notably to identify patients who harbor benign lesions and for whom treatment, particularly the elderly or frail, may be avoided. When performing a RMB to guide initial clinical decision making for small, localized tumors, the most relevant questions are often relegated to proof of malignancy and documentation (if possible) of grade. However, significant intratumoral heterogeneity has been identified in clear cell renal cell carcinoma (ccRCC) that may lead to an underestimation of the genetic complexity of a tumor when single-biopsy procedures are used. Heterogeneous genomic landscapes and branched parallel evolution of ccRCCs with spatially separated subclones creates an illusion of clonal dominance when assessed by single biopsies and raises important questions regarding how tumors can be optimally sampled and whether future evolutionary tumor branches might be predictable and ultimately targetable. This work raises profound questions concerning the genetic landscape of cancer and how tumor heterogeneity may affect, and possibly confound, targeted diagnostic and therapeutic interventions. In this review, we discuss the current role of RMB, the implications of tumor heterogeneity on diagnostic accuracy, and highlight promising future directions.

Citing Articles

Cross-attention enables deep learning on limited omics-imaging-clinical data of 130 lung cancer patients.

Verma S, Magazzu G, Eftekhari N, Lou T, Gilhespy A, Occhipinti A Cell Rep Methods. 2024; 4(7):100817.

PMID: 38981473 PMC: 11294841. DOI: 10.1016/j.crmeth.2024.100817.


Robot-assisted partial nephrectomy in patients aged 75 years or older - comparing the risk of complications with their younger counterparts.

Petersson R, Fode M, Niebuhr M, Rashu B, Thomsen F Aging Clin Exp Res. 2024; 36(1):107.

PMID: 38714631 PMC: 11076407. DOI: 10.1007/s40520-024-02751-5.


Cost-Effectiveness Analysis of the Clear Cell Likelihood Score Against Renal Mass Biopsy for Evaluating Small Renal Masses.

Chen K, Lange M, Qiu J, Lambert D, Mithqal A, Krupski T Urology. 2024; 188:111-117.

PMID: 38648945 PMC: 11193637. DOI: 10.1016/j.urology.2024.04.007.


Prediction of Fuhrman pathological grade of renal clear cell carcinoma based on CT texture analysis.

Dong Z, Guan C, Yang X Am J Clin Exp Urol. 2024; 12(1):28-35.

PMID: 38500865 PMC: 10944366.


The success rate of small renal mass core needle biopsy and its impact on lowering benign resection rate.

Gao H, Nowroozizadeh B, Zepeda J, Landman J, Farzaneh T, Johnson C BMC Urol. 2023; 23(1):189.

PMID: 37980518 PMC: 10657570. DOI: 10.1186/s12894-023-01363-x.


References
1.
Brunelli M, Eccher A, Gobbo S, Ficarra V, Novara G, Cossu-Rocca P . Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma. Mod Pathol. 2007; 21(1):1-6. DOI: 10.1038/modpathol.3800967. View

2.
Klatte T, Rao P, de Martino M, LaRochelle J, Shuch B, Zomorodian N . Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma. J Clin Oncol. 2009; 27(5):746-53. DOI: 10.1200/JCO.2007.15.8345. View

3.
Wang H, Zhu Y, Yao X, Zhang S, Dai B, Zhang H . External validation of a nomogram using RENAL nephrometry score to predict high grade renal cell carcinoma. J Urol. 2012; 187(5):1555-60. DOI: 10.1016/j.juro.2011.12.099. View

4.
Shannon B, Cohen R, de Bruto H, Davies R . The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses. J Urol. 2008; 180(4):1257-61. DOI: 10.1016/j.juro.2008.06.030. View

5.
Gattuso P, Ramzy I, Truong L, Lankford K, Green L, Kluskens L . Utilization of fine-needle aspiration in the diagnosis of metastatic tumors to the kidney. Diagn Cytopathol. 1999; 21(1):35-8. DOI: 10.1002/(sici)1097-0339(199907)21:1<35::aid-dc10>3.0.co;2-#. View